Related Experiment Videos
[Identification of genital papillomavirus using PCR]
1Laboratoire de virologie, Institut de microbiologie, Centre hospitalier universitaire vaudois, Lausanne.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|May 17, 1994
Summary
Human papillomaviruses (HPV) are linked to anogenital tumors, with high-risk types causing cancers. Polymerase Chain Reaction (PCR) aids HPV detection but its clinical use remains debated.
Area of Science:
- Virology
- Oncology
- Genetics
Context:
- Anogenital tract lesions are associated with over 20 human papillomavirus (HPV) types.
- The oncogenic risk varies significantly among HPV types, influencing lesion progression.
- High-risk HPV types (e.g., HPV16, 18) are implicated in most cervical cancers and high-grade anogenital lesions.
Purpose:
- To review the role of HPV in anogenital lesions.
- To discuss the application of Polymerase Chain Reaction (PCR) for HPV detection and typing.
- To evaluate the utility of HPV PCR in clinical practice versus research.
Summary:
- HPV types differ in their association with benign (e.g., HPV6, 11) versus malignant anogenital lesions.
- Polymerase Chain Reaction (PCR) has improved the detection and typing of genital HPV infections.
- While valuable for research and epidemiology, the routine clinical application of HPV PCR is still under discussion, often serving as a supplement to cytology.
Impact:
- Highlights the etiological role of specific HPV types in anogenital cancer development.
- Emphasizes the advancements in diagnostic capabilities for HPV infections.
- Informs the ongoing debate regarding the integration of HPV PCR into routine clinical diagnostics for anogenital conditions.